43338 Federal Register / Vol. 62, No. 156 / Wednesday, August 13, 1997 / Notices

discussions could reveal confidential

trade secrets or commercial property

such as patentable material and

personal information concerning

individuals associated with the

applications, disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

On September 17, from 9 a.m. to 5

p.m., the meeting will be held in

Conference Room 10. This portion of the

meeting will be open to the public for

announcements and reports of

administrative, legislative, and program

developments in the drug abuse field.

Attendance by the public will be limited

to space available.

A summary of the meeting and a

roster of committee members may be

obtained from Ms. Camilla L. Holland,

NIDA Committee Management Officer,

National Institutes of Health, Parklawn

Building, Room 10–42, 5600 Fishers

Lane, Rockville, Maryland 20857, (301/

443–2755).

Substantive program information may

be obtained from Dr. Teresa Levitin,

Room 10–42, Parklawn Building, 5600

Fishers Lane, Rockville, Maryland

20857, (301/443–2755).

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact Dr. Levitin in advance of the

meeting.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.277, Drug Abuse

Research Scientist Development and

Research Scientist Awards; 93.278, Drug

Abuse National Research Service Awards for

Research Training; 93.279, Drug Abuse

Research Programs)

Dated: August 7, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–21421 Filed 8–12–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

Infectious Diseases; Notice of Meeting:

Microbiology and Infectious Diseases

Research Committee

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

Microbiology and Infectious Diseases

Research Committee, National Institute

of Allergy and Infectious Diseases, on

October 6–7, 1997 at the Holiday Inn

Bethesda, Montgomery Room, 8120

Wisconsin Avenue, Bethesda, Maryland.

The meeting will be open to the

public from 8 a.m. to 9:30 a.m. on

October 6, to discuss administrative

details relating to committee business

and for program review. Attendance by

the public will be limited to space

available. In accordance with the

provisions set forth in secs. 552b(c)(4)

and 552b(c)(6), Title 5, U.S.C. and sec.

10(d) of Pub. L. 92–463, the meeting

will be closed to the public for the

review, discussion, and evaluation of

individual grant applications and

contract proposals from 9:30 a.m. until

recess on October 6, and from 8:30 a.m.

until adjournment on October 7. These

applications, proposals and the

discussions could reveal confidential

trade secrets or commercial property

such as patentable material and

personal information concerning

individuals associated with the

applications and proposals, the

disclosure of which would constitute a

clearly unwarranted invasion of

personal privacy.

Ms. Claudia Goad, Committee

Management Officer, National Institute

of Allergy and Infectious Diseases, Solar

Building, Room 3C26, National

Institutes of Health, Bethesda,

Maryland, 301–496–7601, will provide a

summary of the meeting and a roster of

committee members upon request.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact Ms. Goad in advance of the

meeting.

Dr. Gary Madonna, Scientific Review

Administrator, Microbiology and

Infectious Diseases Research Committee,

NIAID, NIH, Solar Building, Room

4C21, Rockville, Maryland 20892,

telephone 301–496–3528, will provide

substantive program information.

(Catalog of Federal Domestic Assistance

Program No. 93.856, Microbiology and

Infectious Diseases Research, National

Institutes of Health)

Dated: August 7, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–21424 Filed 8–12–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Deafness and

Other Communication Disorders;

Notice of Meeting of the National

Deafness and Other Communication

Disorders Advisory Council and its

Planning Subcommittee

Pursuant to Public Law 92–463,

notice is hereby given of the meeting of

the National Deafness and Other

Communication Disorders Advisory

Council and its Planning Subcommittee

on October 8–10, 1997, at the National

Institutes of Health, 9000 Rockville

Pike, Bethesda, Maryland. The meeting

of the full Council will be held in

Conference Room 6, Building 31C, and

the meeting of the subcommittee will be

in Conference Room 7, Building 31C.

The meeting of the Planning

Subcommittee will be open to the

public on October 8 from 2 pm until 3

pm for the discussion of policy issues.

The meeting of the full Council will be

open to the public on October 9 from

8:30 am until 5:00 pm for a report from

the Institute Director and discussion of

extramural policies and procedures at

the National Institutes of Health and the

National Institute on Deafness and

Other Communication Disorders.

Attendance by the public will be limited

to space available.

In accordance with the provisions set

forth in Sections 552b(c)(4) and

552b(c)(6), Title 5, United States Code

and Section 10(d) of Public Law 92–463,

the meeting of the Planning

Subcommittee on October 8 will be

closed to the public from 3 pm to

adjournment. The meeting of the full

Council will be closed to the public on

October 10 from 8 am until

adjournment. The meetings will include

the review, discussion, and evaluation

of individual grant applications and a

report of the Board of Scientific

Counselors. The applications and the

discussions would reveal confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Further information concerning the

Council and Subcommittee meeting may

be obtained from Dr. Craig A. Jordan,

Executive Secretary, National Deafness

and Other Communication Disorders

Advisory Council National Institute on

Deafness and Other Communication

Disorders, National Institutes of Health,